📅 Published
March 20, 2026
(Friday)

Titan Biotech: 50x proof that quality compounds. Revenue ₹60 Cr → ₹300+ Cr. Debt-free. ROCE 20%+.

Stop chasing cheap stocks. Start owning quality.

Watch Short on YouTube

Disclaimer: Educational only. Manish Goel, SEBI Reg. Advisor (INA100007736) | manishgoelstocks.com

📢 Join Our Telegram Channel

Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!

✈️ Join @longtermequityy on Telegram

🔔 Free • No spam • Value investing insights daily

₹8 to ₹400 — 50x Returns! The Secret of Quality Investing #Shorts
author avatar
Manish Goel
Manish Goel is a long-term value investor and the founder of Manish Goel Stocks, where he publishes daily, plain-English lessons on fundamental analysis for Indian investors. His writing focuses on reading annual reports, decoding financial ratios, spotting red flags, and building the patience and discipline that compounding rewards. Every article here is educational — never a buy or sell call — and free to read.
See Full Bio